Weight loss drugs and CMS coverage: Why all eyes are on Medicare
(By Rylee Wilson for Becker’s Hospital Review) New GLP-1 drugs to treat diabetes and obesity can be expensive, and most
Read More
Medicare – General
The Facts About Medicare Spending
(Source – The Kaiser Family Foundation Published June 2023) Medicare provides health insurance coverage for more than 65 million people,
Read MoreWhy some physicians are breaking up with Medicare
(By Riz Hatton for Becker’s Hospital Review) Sixty-five percent of physicians plan to continue treating Medicare and Medicaid patients, according
Read MoreFor many who use power wheelchairs, CMS decision just made seat elevation much less expensive
(By Kerry Dooley Young for STAT) For years, patients and medical groups have advocated for Medicare to cover wheelchairs with
Read MoreScience finally figured out how to make effective RSV vaccines. Will seniors care?
(By Helen Branswell for STAT) The world has waited decades for vaccines to protect older adults against RSV. One, made
Read MoreCMS: Dual-eligible Medicare Advantage members less likely to receive cancer screenings, mental healthcare
(By Rylee Wilson for Becker’s Hospital Review) Individuals who are dually eligible for Medicare and Medicaid had lower scores on
Read MoreHow Medicare’s Aduhelm decision revived old questions about new drugs
(By Kerry Dooley Young for STAT) Medicare’s decision to withhold coverage for Biogen’s Aduhelm despite the Food and Drug Administration’s
Read MoreMedicare payers vow to keep covering remote patient monitoring
(By Giles Bruce for Becker’s Hospital Review) Private insurance companies that contract for Medicare will continue to pay for remote
Read More6 recent Medicare Advantage study findings
(By Rylee Wilson for Becker’s Hospital Review) Medicare Advantage and traditional Medicare can differ on clinical quality and costs, but
Read MoreNew Alzheimer’s Drugs Spark Hope for Patients and Cost Concerns for Medicare
(By Juliette Cubanski and Tricia Neuman for Kaiser Family Foundation published May 18, 2023) The FDA’s accelerated approval of Aduhelm
Read More